1Hahn RG, Shemais H, Essen P. Glycine 1.0% versus glycine 1.5% as irrigating fluid during transurethral resection of the prostate. Br J Urol 1997; 79(3):394-400.
2Iori F, Franco G, Leonardo C, et al. Bipolar transurethral resection of prostate: clinical and urodynamic evaluation. Urology 2008; 71(2): 252-255.
3Fastenmeier K. Transurcthral surgery. Berlin: SpringerVerlag, 1983. 350-350.
4Cetinkaya M, Ozturk B, Akdemir O, et al. A comparison of fluid absorption during transurethral resection and transurethral vaporization for benign prostatic hyperplasia. BJU Int, 2000, 86: 820-823.
5Mebust W K,Holtgrewe H L,Cockett A T.Transurethral prostatectomy immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3885 patients[].Journal d Urologie.2002
6Collins JW,Macdermott S,Bradbrook RA.A comparison of the effect of1.5%glycine and5%glucose irrigants on plasma serum physiology and the inci-dence of transurethral resectionsyn-drome during prostate resection[].BJU International.2005
7Schober,Patrick MD,et al.Transurethral Resection Syndrome Detected and Managed Using Transesophageal Doppler[].Anesthesia and Analgesia.2008
8Park J,Lee S,SH Hanet al.Is Warm Temperature Necessary to Pre-vent Urethral Stricture in Combined Transurethral Resection and Va-porization of Prostate?[].Urology.2009
9Walsh PC,Retik AB,Vaughan E,et al.Campbell s urology[]..1999
10Hubert J,Cormier L,Gerbaud P F,et al.Computer-controlled monitoring of bladder pressure in the prevention of TUR syndrome: a randomized study of 53 cases[].British Journal of Urology.1996
1Gacci M,Corona G,Salvi M,et al.A systematic review and metaanalysis on the use of phosphodiesterase 5 inhibitors alone or in combination withα-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.Eur Urol,2012,61(5):994-1003.
2Shrivastava A,Gupta VB.Various treatment options for benign prostatic hyperplasia:A current update.J Midlife Health,2012,3(1):10-19.
3Kaplan SA,Chung DE,Lee RK,et al.A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia:finasteride has comparable urinary symptom efficacy and prostate volume reduction.but less sexual side effects and breast complications than dutasteride.Int J Clin Pract,2012,66(11):1052-1055.
